University, Diss., 2004--München.

Chinese hamster ovary cells (CHO) were arrested with hydoxyurea at the beginning of DNA synthesis. Subsequent treatment with caffeine induced cells to bypass S-phase and undergo mitosis with unreplicated genomes (MUG). Treated cells built a normal spindle and distributed unattached kinetochores to daughter cells. To determine if MUG cells obey the metaphase checkpoint, we used immunoflourescence to detect and localize known metaphase checkpoint and motor proteins. In addition, the drug taxol was used to stabilize microtubules in MUG cells. The localization of CENP- E, the presence of anaphase A, taxol arrest, and taxol release acted in a similar manner as in controls. The localization of kinesin differed from the controls and that of MAD2 was inconclusive. These results imply that MUG kinetochores behave similarly to controls and probably have an operational metaphase checkpoint.

The aim of this research was to identify the molecular mechanisms that promote spontaneous activation in rat eggs after their recovery from the oviduct. Typically, mammalian eggs await fertilisation arrested at the second metaphase II of meiosis. However, ovulated rat eggs spontaneously enter anaphase II when exposed to in vitro culture. After extrusion of the second polar body, these spontaneously activated eggs do not proceed to interphase but become arrested at metaphase III stage with chromatids scattered in the egg cytoplasm. This instability may be one factor that has made it more difficult to establish reliable protocols for somatic cell nuclear transfer in rats. The triggers of spontaneous activation and signalling pathways leading to the metaphase III progression are largely unknown. Analyses of signalling pathways that are involved in the regulation of final stages of meiosis during fertilisation revealed several anomalies that were associated with spontaneous activation and the transition from metaphase II to metaphase III. Metaphase II arrested eggs usually exhibit an increased level of maturation promoting factor (MPF) activity. Spontaneous activation in rat eggs was associated with a drop in MPF activity at the time of the second polar body extrusion. MPF is composed of a catalytic subunit, CDK1, and a regulatory subunit, cyclin B1. Interestingly, the level of cyclin B1 was stable throughout spontaneous activation. Post-translational modifications of CDK1 can influence MPF activity: whereas no inhibitory phosphorylation on Tyr15 of CDK1 was found; a decrease in activating Thr161 phosphorylation of CDK1 was associated with the time of the second polar body extrusion, and hence could contribute to the transient MPF inactivation. MAPK (p42/p44) activity has been shown to decrease during egg activation in fertilisation. By contrast, during spontaneous activation, MAPK (p42/p44) remained active and thus resembled the profile usually found between two meiotic divisions (metaphase I to metaphase II). Securin, a protein which prevents premature chromatid separation, was degraded in eggs going through spontaneous activation. Cytostatic factor (CSF) is a biochemical activity, which enables stable metaphase II arrest in ovulated eggs of vertebrates. Recently, the endogenous meiotic inhibitor 2, EMI2, was confirmed as the major component of CSF. For egg activation to occur, the CSF must be destroyed. At the beginning of egg activation, Ca2+/calmodulin kinase (CaMKII) promotes posttranslational modifications of EMI2, leading to its degradation. In the rat, inhibition of CaMKII activity stably prevented the onset of spontaneous activation in a subset of metaphase II eggs. However, no degradation of EMI2 protein was found at the start of abortive metaphase II exit. This finding revealed that one of the central elements of the CSF pathway, EMI2, could be preserved in the rat eggs going through spontaneous activation. In order to study the mechanisms regulating EMI2 stability in rat oocyte maturation and spontaneous activation, functional analysis of ectopically expressed synthetic mRNA was performed. The mechanism enabling EMI2 degradation became active 12 hours after the start of oocyte maturation. The C-terminal fragment of EMI2, known to be non-degradable in Xenopus oocyte maturation, was significantly more stable than the full-length counterpart in matured rat eggs but not during oocyte maturation. Interestingly, C-terminal EMI2 became degraded in parthenogenetic rat embryos. This indicated that additional not previously reported mechanisms responsible for EMI2 degradation might exist in the rat. The microinjection of metaphase II rat eggs with the C-terminal fragment of EMI2 or IVT full-length EMI2 protein had little effect on the progression of spontaneous activation. Taken together, these observations suggest that abortive spontaneous activation in rat eggs was a result of incomplete engagement of signalling pathways normally triggered in fertilisation or parthenogenetic activation. Activation of CaMKII initiated pathways that allowed anaphase entry and chromatid segregation. At the same time, not all pathways normally triggered during fertilisation or parthenogenetic activation were fully engaged, possibly due to the presence of non-degraded component of CSF. Abortive incomplete activation results in the re-establishment of high level of MPF activity in metaphase III eggs. Early prevention of CaMKII activation, perhaps by blocking [Ca2+ i] signalling, may provide a means of holding ovulated eggs at metaphase II prior to enucleation and somatic cell nuclear transfer.

Student Number : 9901196J - MSc dissertation - School of Pathology - Faculty of Science / Fragile sites are highly unstable regions of the genome, which have a tendency to form gaps and breaks in metaphase chromosomes under replication stress conditions. There are many common fragile sites in the human genome and exposure to carcinogens may affect several genes localised in fragile sites within a single cell, which could lead to activation of oncogenes and inactivation of tumour-suppressor genes simultaneously. FRA3B on chromosome 3 and FRA16D on chromosome 16 are the two most commonly expressed fragile sites and contain the FHIT and WWOX genes respectively. These genes are tumour suppressor genes and are inactivated in a number of different ways. Carcinogens found in cigarette smoke have been found to increase fragile site expression and could alter the integrity of theses genes in active smokers. Ten healthy non-smoking (control) individuals and twenty active smokers were recruited for the purpose of this study. Fluorescence in situ hybridisation was performed with probes spanning spanning the FHIT gene and RT-PCR was performed to assess both FHIT and WWOX expression. No significant difference in breaks at fragile sites was observed between controls and active smokers in the FISH experiments. In addition, no aberrant transcripts were detected for either FHIT or WWOX with RT-PCR. Although the sampling group was limited and heterogenous, no increase in the expression of breaks at fragile sites was seen in active smokers in the present study.

Thesis (Ph. D.)--Case Western Reserve University, 2005. / [School of Medicine] Department of Environmental Health Sciences. Includes bibliographical references. Available online via OhioLINK's ETD Center.

The research presented in this dissertation consists of four papers that revolve around the structure of human chromosomes and their relationship to birth defects. A new technique is described to produce spiralization of human metaphase chromosomes. The important feature is heat followed by trypsin treatment. By varying conditions, it is possible to produce bands, spirals and intermediate states. An investigation of human metaphase chromosomes reveals identical lateral bands in sister chromatids when stained with Quinacrine mustard or Giemsa-trypsin. A hybrid of these two methods produces banding patterns which are different in sister chromatids yet may be repeated in homologous chromatids. A case study is presented in which a 3l-year old white female with a history of ovarian dysfunction and infertility delivered a male infant with trisomy 13. Her cultured leucocytes were mosaic for trisomy X. The natures of trisomy X and trisomy 13 are discussed with particular emphasis on the genetic transmission. In another case study of a family, it is found that some individuals who completely lack dermal ridges are mosaic for an extra X chromosome with deletions in both arms. A mechanism is proposed to account for the extra chromosome. / Ph. D.

As síndromes mielodisplásicas (SMD) constituem um grupo heterogêneo de doenças hematológicas de origem clonal, caracterizado por hematopoese ineficaz, citopenia e risco de evolução para leucemia mieloide aguda (LMA). As anormalidades citogenéticas adquiridas são marcadores prognósticos bem estabelecidos em SMD. No entanto, a técnica de citogenética metafásica apresenta limitações, incluindo baixa resolução e necessidade de divisão celular, sendo que defeitos cromossômicos podem não ser detectados. Tecnologias baseadas em microarranjo (array) de DNA, como o Single Nucleotide Polymorphism Array (SNP-A), são importantes para avaliação do genoma normal e neoplásico. O SNP-A foi desenvolvido para o estudo de todo o genoma, apresenta uma resolução superior a citogenética metafásica convencional, pode ser realizado em células na interfase, e detecta alterações cromossômicas não visualizadas pela citogenética metafásica. Além disso, o SNPA fornece dados de genotipagem para detecção de perda neutra de heterozigose, também denominada de dissomia uniparental somática. Regiões cromossômicas com deleção, perda neutra de heterozigose ou ganho são comuns em pacientes com neoplasias hematológicas e sugeriu genes candidatos a supressores de tumor e oncogenes. O objetivo do presente estudo foi a caracterização da coorte de pacientes com suspeita clínica de SMD e o uso integrado do método de citogenética convencional e SNP-A no serviço de hematologia da nossa instituição na investigação de alterações citogenéticas em pacientes com SMD e doenças relacionadas. Durante o período do estudo, foram recebidas um total de 114 amostras de pacientes com suspeita clínica de SMD. A análise clínica, morfológica e citogenética permitiu confirmar o diagnóstico de SMD ou doenças relacionadas em 43 pacientes (SMD [n=34], SMD/NMP [n=5], LMA com alterações mielodisplásicas [n=4]). Vinte e um pacientes foram classificados como citopenia idiopática de significado indeterminado (CISI) e 50 indivíduos apresentaram outros diagnósticos. SNP-A foi realizado em 17 pacientes com SMD e doenças relacionadas. Dentre os pacientes selecionados para o SNP-A, anormalidades cromossômicas foram observadas em 6/17 (35%) casos pelo cariótipo convencional e em 8/17 (47%) casos pela técnica de SNP-A. SNP-A não detectou quatro alterações cromossômicas previamente identificadas pela citogenética convencional: duas translocações balanceadas e duas alterações numéricas. SNP-A confirmou os demais achados identificados pela citogenética convencional e detectou um total de 32 novas lesões (1 ganho, 19 perdas e 12 UPDs) em 6 pacientes com SMD ou doenças relacionadas. SNP-A pode complementar a citogenética convencional na detecção de anormalidades cromossômicas em neoplasias mieloides. / Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic diseases, characterized by inefficient hematopoiesis, peripheral blood cytopenias and a risk to progress to acute myeloid leukemia (AML). Acquired chromosomal abnormalities have prognostic value in MDS. However, metaphase cytogenetics has some limitations including low resolution and the requirement of cell division, and chromosomal abnormalities may not be detected. New technologies based on array, the Single Nucleotide Polymorphism Array (SNP-A), are able to evaluate the whole genome. The SNP-A has superior resolution compared to metaphase cytogenetics, may be used in interphase cells, and may detect chromosomal abnormalities not detected by metaphase cytogenetics. In addition, the SNP-A read-out includes genotyping calls and hybridization signal strength, corresponding to gene copy number, allowing detecting copy neutral loss of heterozigosity (CN-LOH), also known as uniparental dissomy (UPD). Deletions, copy neutral loss of heterozigosity or gain are frequent in patients with haematopoietic neoplasms and has already suggested the location of tumor suppressor genes and oncogenes. The aim of this study was to characterize the cohort of patients with clinical suspicion of MDS and to establish the integrative use of the conventional cytogenetic and the SNP-A in the investigation of chromosomal abnormalities in patients with MDS and related diseases followed at our institution. The clinical, morphological and cytogenetic evaluation allowed us to confirm the diagnosis of MDS or related disease in 43 patients (MDS [n=34], MDS/MPN [n=5], AML with myelodysplastic changes [n=4]). Twenty-one patients were diagnosed with idiopathic cytopenia with undetermined significance (ICUS) and 50 patients had other diagnosis. SNP-A were performed in 17 patients with MDS and related disease. Chromosomal abnormalities were observed in 6/17 (35%) cases by metaphase cytogenetics, and in 8/17 (47%) of the cases by SNP-A. SNP-A did not detected two balanced translocations and two numerical alterations previously observed by metaphase cytogenetics. SNP-A confirmed all the other findings observed by metaphase cytogenetics and SNP-A detected a total of 32 new lesions (1 gain, 19 losses and 12 UPDs) in 6 MDS and related diseases. SNP-A may complement metaphase cytogenetics to improve the detection of chromosomal abnormalities in myeloid neoplasms.

As síndromes mielodisplásicas (SMD) constituem um grupo heterogêneo de doenças hematológicas de origem clonal, caracterizado por hematopoese ineficaz, citopenia e risco de evolução para leucemia mieloide aguda (LMA). As anormalidades citogenéticas adquiridas são marcadores prognósticos bem estabelecidos em SMD. No entanto, a técnica de citogenética metafásica apresenta limitações, incluindo baixa resolução e necessidade de divisão celular, sendo que defeitos cromossômicos podem não ser detectados. Tecnologias baseadas em microarranjo (array) de DNA, como o Single Nucleotide Polymorphism Array (SNP-A), são importantes para avaliação do genoma normal e neoplásico. O SNP-A foi desenvolvido para o estudo de todo o genoma, apresenta uma resolução superior a citogenética metafásica convencional, pode ser realizado em células na interfase, e detecta alterações cromossômicas não visualizadas pela citogenética metafásica. Além disso, o SNPA fornece dados de genotipagem para detecção de perda neutra de heterozigose, também denominada de dissomia uniparental somática. Regiões cromossômicas com deleção, perda neutra de heterozigose ou ganho são comuns em pacientes com neoplasias hematológicas e sugeriu genes candidatos a supressores de tumor e oncogenes. O objetivo do presente estudo foi a caracterização da coorte de pacientes com suspeita clínica de SMD e o uso integrado do método de citogenética convencional e SNP-A no serviço de hematologia da nossa instituição na investigação de alterações citogenéticas em pacientes com SMD e doenças relacionadas. Durante o período do estudo, foram recebidas um total de 114 amostras de pacientes com suspeita clínica de SMD. A análise clínica, morfológica e citogenética permitiu confirmar o diagnóstico de SMD ou doenças relacionadas em 43 pacientes (SMD [n=34], SMD/NMP [n=5], LMA com alterações mielodisplásicas [n=4]). Vinte e um pacientes foram classificados como citopenia idiopática de significado indeterminado (CISI) e 50 indivíduos apresentaram outros diagnósticos. SNP-A foi realizado em 17 pacientes com SMD e doenças relacionadas. Dentre os pacientes selecionados para o SNP-A, anormalidades cromossômicas foram observadas em 6/17 (35%) casos pelo cariótipo convencional e em 8/17 (47%) casos pela técnica de SNP-A. SNP-A não detectou quatro alterações cromossômicas previamente identificadas pela citogenética convencional: duas translocações balanceadas e duas alterações numéricas. SNP-A confirmou os demais achados identificados pela citogenética convencional e detectou um total de 32 novas lesões (1 ganho, 19 perdas e 12 UPDs) em 6 pacientes com SMD ou doenças relacionadas. SNP-A pode complementar a citogenética convencional na detecção de anormalidades cromossômicas em neoplasias mieloides. / Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic diseases, characterized by inefficient hematopoiesis, peripheral blood cytopenias and a risk to progress to acute myeloid leukemia (AML). Acquired chromosomal abnormalities have prognostic value in MDS. However, metaphase cytogenetics has some limitations including low resolution and the requirement of cell division, and chromosomal abnormalities may not be detected. New technologies based on array, the Single Nucleotide Polymorphism Array (SNP-A), are able to evaluate the whole genome. The SNP-A has superior resolution compared to metaphase cytogenetics, may be used in interphase cells, and may detect chromosomal abnormalities not detected by metaphase cytogenetics. In addition, the SNP-A read-out includes genotyping calls and hybridization signal strength, corresponding to gene copy number, allowing detecting copy neutral loss of heterozigosity (CN-LOH), also known as uniparental dissomy (UPD). Deletions, copy neutral loss of heterozigosity or gain are frequent in patients with haematopoietic neoplasms and has already suggested the location of tumor suppressor genes and oncogenes. The aim of this study was to characterize the cohort of patients with clinical suspicion of MDS and to establish the integrative use of the conventional cytogenetic and the SNP-A in the investigation of chromosomal abnormalities in patients with MDS and related diseases followed at our institution. The clinical, morphological and cytogenetic evaluation allowed us to confirm the diagnosis of MDS or related disease in 43 patients (MDS [n=34], MDS/MPN [n=5], AML with myelodysplastic changes [n=4]). Twenty-one patients were diagnosed with idiopathic cytopenia with undetermined significance (ICUS) and 50 patients had other diagnosis. SNP-A were performed in 17 patients with MDS and related disease. Chromosomal abnormalities were observed in 6/17 (35%) cases by metaphase cytogenetics, and in 8/17 (47%) of the cases by SNP-A. SNP-A did not detected two balanced translocations and two numerical alterations previously observed by metaphase cytogenetics. SNP-A confirmed all the other findings observed by metaphase cytogenetics and SNP-A detected a total of 32 new lesions (1 gain, 19 losses and 12 UPDs) in 6 MDS and related diseases. SNP-A may complement metaphase cytogenetics to improve the detection of chromosomal abnormalities in myeloid neoplasms.

Many primate populations face the threat of extinction due to habitat loss, intensive agriculture, hunting for meat, the pet trade and/or use in traditional medicines. An alternative approach to in situ conservation includes gene banking and the use of assisted reproductive technologies (ART), such as oocyte in vitro maturation (IVM) and in vitro fertilization (IVF). Although many of these 'high-tech' solutions have not yet been proven viable for pragmatic wildlife conservation, basic research and development of these emerging tools can provide necessary information needed to optimize these techniques and institute ART as a routine practice in conservation efforts. A severely limiting factor in the successful application of ARTs is the availability of mature developmentally competent oocytes. Oocyte maturation involves many nuclear and cytoplasmic factors, which can be affected by maturation conditions and female age. In vitro maturation does not have the same success rate across species studied. In primates especially, IVM oocytes exhibit reduced developmental capacity upon fertilization when compared to in vivo matured (IVO) oocytes. This study aimed to investigate possible causes of reduced developmental capacity of primate IVM oocytes using the rhesus macaque (Macaca mulatta) as a model. Research efforts included investigation of ovarian senescence, oocyte karyotype and spindle morphology, and establishment of an optimal sperm cryopreservation protocol for use in IVF. Histological examination of the rhesus ovary demonstrated an age-related pattern of follicle depletion similar to that described in the human ovary. Oocyte karyotype analysis revealed a significant effect of IVM on the frequency of hyperhaploidy. In addition, immunostaining and confocal microscopy demonstrated a significant increase of anomalous chromosome congression on the oocyte metaphase II spindle equator in relation to IVM and donor female age. These results indicate that IVM can produce serious, if not lethal consequences for embryo development. This study presents baseline data on ovarian aging in the rhesus macaque and aspects of nuclear maturation during macaque IVM that may contribute to the design of primate oocyte recovery plans. Implementation of either of two sperm cryopreservation methods originally developed for rhesus and vervet monkeys will aid future investigation of the developmental capacity of IVM oocytes.

Nlrp5, a maternal-effect gene, is required for embryonic progression and female fertility in mice. Previous work indicated an age-related decline in Nlrp5 transcripts in murine oocytes. As maternal age is associated with increased spindle organization defects, studies in this thesis focused on the analysis of meiotic spindle defects in oocytes of Nlrp5-deficient mice. NALP5 protein showed a novel kinetochore-localization pattern, which was disturbed by spindle poisons. Nlrp5-deficient oocytes displayed a higher frequency of spindle abnormalities and chromosomal misalignment. Upon fertilization, these defects translated into increased incidences of multinucleation. As these phenotypes are associated with deficiencies in genome stability, we examined spindle assembly checkpoint (SAC) components. We found that numerous SAC proteins were dysregulated, implying that NALP5 may be critical in sensing oocyte-related SAC defects. We found that Nlrp5-deficient oocytes may have increased DNA damage. Thus, Nlrp5 may be an integral component responsible for preservation of genome integrity in female gametes.